Pathfinder - Blood Lords: Graveclaw [PZO90182] $26.99 Value

Pathfinder - Blood Lords: Graveclaw [PZO90182] $26.99 Value

Marsoni

M251S

$19.95

Get it in 3 business days with 1 day shipping. Friday, May 29

Pathfinder - Blood Lords: Graveclaw [PZO90182] $26.99 ValuePathfinder Blood Lords: Graveclaw [PZO90182] $26. 99 Value Toil and Trouble! After stopping a poisonous plot against the living population of Graydirge, the player characters must seek out the hag pulling the strings from behind the scenes. Yet hags congregate in covens, and facing off against the insidious hag coven called the Graveclaw leads to a race across the undead haunted nation of Geb. From shadowed forests to an undersea temple, and from

Easy Shipping

Quick Dispatch:

Your Pathfinder - Blood Lords: Graveclaw [PZO90182] $26.99 Value orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Pathfinder - Blood Lords: Graveclaw [PZO90182] $26.99 Value ships.

Need Help?
Questions about Pathfinder - Blood Lords: Graveclaw [PZO90182] $26.99 Value, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Pathfinder - Blood Lords: Graveclaw [PZO90182] $26.99 Value in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

If I could give this zero stars, I absolutely would. I ordered these shoes expecting them to be brand new since I paid full price and never selected any “used” option. What I received instead were clearly heavily worn shoes there were visible signs of use that you simply wouldn’t expect from a new product.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on March 25, 2026